Investors

Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds

Webcast ImageWebcast
AcelRx Pharmaceuticals, Inc. at Jefferies Global Heatlhcare Conference - London (Replay)
11/19/14 at 12:00 p.m. UKT
AcelRx Pharmaceuticals, Inc. at Jefferies Global Heatlhcare Conference - London
Wednesday, November 19, 2014  through Thursday, November 20, 2014 
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
AcelRx Pharmaceuticals, Inc. at Piper Jaffray Healthcare Conference  (Live)
12/02/14 at 12:00 p.m. ET
AcelRx Pharmaceuticals, Inc. at Piper Jaffray Healthcare Conference
Tuesday, December 2, 2014  through Wednesday, December 3, 2014 
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, Zalviso, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the complexity of infusion pumps. AcelRx has announced positive results from each of the three Phase 3 clinical trials for Zalviso and has submitted an NDA to the FDA seeking its approval. AcelRx also announced positive top-line results for a Phase 2 trial for ARX-04, a sufentanil formulation for the treatment of moderate-to-severe acute pain, funded through a grant from U.S. Army Medical Research and Materiel Command. The company has two additional pain treatment product candidates, ARX-02 and ARX-03, which have completed Phase 2 clinical development.
ACRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$6.50
Change (%) Stock is Down 0.12 (1.81%)
Volume338,114
Data as of 11/21/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Recent News

    More >>
11/20/14AcelRx Pharmaceuticals to Participate in Four Upcoming Investor Events
REDWOOD CITY, Calif., Nov. 20, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that senior management will be participating at Piper Jaffray, RBC, Guggenheim and Roth Healthcare Conferences. Details of the events are as follows: Piper Jaffray Healthcare Conference 2014 Date: Tuesday, December 2nd Locat... 
Printer Friendly Version
11/13/14AcelRx Pharmaceuticals Announces Zalviso™ Sublingual Sufentanil Data Presentation At The American Society Of Regional Anesthesia And Pain Medicine Meeting
Data from Sublingual Sufentanil Tablet System Development Program Highlights Efficacy across Various Demographic Populations REDWOOD CITY, Calif., Nov. 13, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that a moderated poster presentation will be made at the American Society of Regional Anesthesia and P... 
Printer Friendly Version
11/10/14AcelRx Pharmaceuticals Receives International Standards Organization (ISO) 13485:2003 Certification of its Quality Management System
REDWOOD CITY, Calif., Nov. 10, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has been granted International Standards Organization (ISO) 13485:2003 certification of its quality management system, an internationally recognized quality standard for medical devices issued by the British Standards Inst... 
Printer Friendly Version

Upcoming Events

    More >>
DateTitle
12/02/14
through
12/03/14
AcelRx Pharmaceuticals, Inc. at Piper Jaffray Healthcare Conference
LocationThe New York Palace
New York City, NY US

Receive E-mail Alerts 

Sign up to receive e-mail alerts whenever AcelRx Pharmaceuticals, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

AcelRX

CONTACT